Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2010
11/25/2010US20100297648 Method for diagnosing susceptibility to post-traumatic scar-tissue formation
11/25/2010US20100297647 Polymerase-based single-molecule sequencing
11/25/2010US20100297646 Method for detection of cancer
11/25/2010US20100297645 Automatic detection of infectious diseases
11/25/2010US20100297644 High throughput nucleic acid sequencing by spacing
11/25/2010US20100297643 Terminus-Specific DNA Modification Using Random-Sequence Template Oligonucleotides
11/25/2010US20100297642 Method for determining frameshift mutations in coding nucleic acids
11/25/2010US20100297641 Methylation altered dna sequences as markers associated with human cancer
11/25/2010US20100297640 Hand held micro pcr device
11/25/2010US20100297639 Quantitative/semi-quantitative measurement of epor on cancer cells
11/25/2010US20100297638 Molecular adaptors
11/25/2010US20100297637 Primer for amplification of rrna or bacterium belonging to the genus legionella, detection method, and detection kit
11/25/2010US20100297636 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
11/25/2010US20100297635 Collection and measurement of exhaled particles
11/25/2010US20100297634 Gene expression signatures in enriched tumor cell samples
11/25/2010US20100297633 Method of amplifying nucleic acid
11/25/2010US20100297632 Upregulation of rack-1 in melanoma and its use as a marker
11/25/2010US20100297631 Compositions and Methods For Detecting Histamine Related Disorders
11/25/2010US20100297630 Method for the simultaneous detection of multiple nucleic acid sequences in a sample
11/25/2010US20100297629 Nucleic acid supported protein complementation
11/25/2010US20100297628 Methods Of Producing And Sequencing Modified Polynucleotides
11/25/2010US20100297627 MicroRNA Diagnostics for Cancer
11/25/2010US20100297626 Reagents, Methods, and Libraries for Bead-Based Sequencing
11/25/2010US20100297625 Biomarkers for psychosis
11/25/2010US20100297624 Involvement of Lipid Kinase, and Signal Transduction Pathway Comprising Said Lipid Kinase, in Resistance to HER2-Targeting Therapy
11/25/2010US20100297623 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
11/25/2010US20100297622 Method for high-throughput gene expression profile analysis
11/25/2010US20100297621 Use of pre-mrna splicing in platelet cells for the diagnosis of disease
11/25/2010US20100297620 Activated protease indicator
11/25/2010US20100297619 Genetic prediction of schizophrenia susceptibility
11/25/2010US20100297618 Methods for determining a prognosis of colorectal cancer
11/25/2010US20100297617 Primer set for amplifying nat2 gene, reagent for amplifying nat2 gene containing the same, and the uses thereof
11/25/2010US20100297616 Situ hybridisation method
11/25/2010US20100297615 Egfr mutations
11/25/2010US20100297614 Process for the detection of cytosine methylations
11/25/2010US20100297613 Nucleic acid, amino acid encoded by said nucleic acid, probe comprising said nucleic acid or said amino acid, and screening method using said probe
11/25/2010US20100297612 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
11/25/2010US20100297611 Method and Device For Combined Detection Of Viral And Bacterial Infections
11/25/2010US20100297610 Molecularly imprinted polymers for detecting hiv-1
11/25/2010US20100297609 Vivo isotopic labeling method for quantitative glycomics
11/25/2010US20100297608 Systems and Methods for CMOS-Compatible Silicon Nano-Wire Sensors with Biochemical and Cellular Interfaces
11/25/2010US20100297607 Reagents For HCV Antigen-Antibody Combination Assays
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297605 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c
11/25/2010US20100297604 Methods and reagents for virus isolation and detection
11/25/2010US20100297603 Analyte-releasing beads and use thereof in quantitative elispot or fluorispot assay
11/25/2010US20100297602 Apparatus and method of contaminant detection
11/25/2010US20100297601 Small volume and ultra speed colorimetric sensor
11/25/2010US20100297292 Reduced Pigmentation Microalgae Strains and Products Therefrom
11/25/2010US20100297215 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/25/2010US20100297183 Immunogenic streptococcus proteins
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297158 Anticancer vaccine and diagnostic methods and reagents
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297148 Cd38 modulated chemotaxis
11/25/2010US20100297147 Compositions and methods for modulating tlr14 activity
11/25/2010US20100297145 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297127 Use of il-27 antagonists to treat lupus
11/25/2010US20100297126 Monoclonal Antibodies Specific to Hemagglutinin from Influenza Virus H5-Subtype and Uses Thereof
11/25/2010US20100297087 Pluripotent stem cells characterized by expression of germline specific genes
11/25/2010US20100297067 Methylation markers for prostate cancer and methods of use
11/25/2010US20100297021 Variants of C-Type Natriuretic Peptide
11/25/2010US20100297018 Prognosis and therapy of liver failure
11/25/2010US20100297016 Quarternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
11/25/2010US20100297015 Cancer biomarker and uses thereof
11/25/2010US20100297014 Method of detecting the risk of cancer using genetic markers
11/25/2010US20100297010 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/25/2010US20100296963 Crystal structure of a plasma membrane proton pump
11/25/2010US20100296711 Method of determining a biospecies
11/25/2010US20100294723 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
11/25/2010CA2799995A1 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
11/25/2010CA2763016A1 Targeting micrornas for metabolic disorders
11/25/2010CA2762987A1 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
11/25/2010CA2762986A1 Mirna biomarkers of prostate disease
11/25/2010CA2762611A1 Blood coagulation time prolonging agent
11/25/2010CA2762586A1 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs
11/25/2010CA2762566A1 Methods for whole-cell analysis of gram-positive bacteria
11/25/2010CA2762525A1 Marked peptides and use thereof for assaying circulating irap
11/25/2010CA2762369A1 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
11/25/2010CA2761125A1 Genetic markers associated with interferon-alpha response
11/25/2010CA2761059A1 A dried and stabilized ready-to-use composition containing nucleic acid polymerization enzymes for molecular biology applications
11/25/2010CA2759939A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
11/24/2010EP2253722A2 Reagent and methods for detecting severe acute respiratory syndrome coronavirus
11/24/2010EP2253721A1 Method for predicting the occurence of lung metastasis in breast cancer patients
11/24/2010EP2253720A2 Method for detecting esophageal carcinoma and agent for suppressing esophageal carcinoma
11/24/2010EP2253719A2 Diagnosing and monitoring transplant rejection based on marker expression levels
11/24/2010EP2253718A2 Solid surface for biomolecule delivery and high-throughput assay
11/24/2010EP2253717A1 Method of amplifying nucleic acid by using double-stranded nucleic acid as template
11/24/2010EP2253716A1 Diagnostic methods for the prognosis of a brain tumor
11/24/2010EP2253715A1 New targets for cancer therapy and/or diagnosis
11/24/2010EP2253714A1 Lung cancer detecting method using lung cancer specific methylation marker genes
11/24/2010EP2253713A2 Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
11/24/2010EP2253712A1 Method of distinguishing inflammatory pathogen causing acute respiratory infection
11/24/2010EP2253711A1 Methods, compositions and a kit suitable for determining the concentration of gamma-hydroxy butyric acid (GHB) in a sample
11/24/2010EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/24/2010EP2253704A1 Oligonucleotide mediated nucleic acid recombination
11/24/2010EP2253702A1 High throughput assay of LP-PLA2 activity